TSS:Hg 36385.1

Basic information about the TSS

---

TSS ID: hg_36385.1 Species: human Chr: chr3		Start: 45593875 End: 45593898 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000440097.5 Distance: 426 GeneID: 8994 HGNC/MGI_ID: HGNC:6612 UniProt_ID: C9JRJ5

Gene_name: LIM domain containing 1 Gene_symbol: LIMD1 Gene_synonyms: Gene_source: HGNC:6612

TATA-Box annotation

---

Distance to TSS:	-864
Nearest PromoterID:	NM_014240
Entrez ID:	8994
Nearest Unigene:	Hs.193370
Nearest Refseq:	NM_014240
Nearest Ensembl:	ENSG00000144791
Gene Name:	LIM domain containing 1
Gene Alias:	-
Gene Description:	LIM domains containing 1
Gene Type:	protein-coding
CpG%:	0.1
GC%:	0.731343
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LIMD1 p2@LIMD1 p3@LIMD1 p4@LIMD1
Sample		p1@LIMD1	p2@LIMD1	p3@LIMD1	p4@LIMD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.60	2.73	8.38	2.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	39.45	1.62	4.05	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	32.02	2.12	6.17	6.94
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	24.53	1.04	6.03	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	30.15	2.02	5.40	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	34.89	3.29	6.98	4.07
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.90	3.70	9.15	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.61	3.39	10.66	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.39	2.78	9.40	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.61	1.16	5.80	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.21	2.02	4.45	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	1.63	8.13	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.50	4.03	1.45	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.94	3.16	0.90	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.27	2.85	1.76	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.85	2.77	2.01	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.73	1.97	1.09	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.83	5.06	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	4.80	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.29	3.46	1.35	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.64	4.95	1.47	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	17.95	4.32	2.93	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.03	3.88	1.81	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.59	2.91	2.43	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.90	3.35	1.03	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.51	2.53	0.95	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	3.85	2.20	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.22	5.19	3.06	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.41	3.39	1.45	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	3.44	1.99	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	14.44	2.51	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.09	2.93	1.76	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	15.19	3.38	0.84	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.36	3.96	1.15	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.40	2.06	2.06	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.63	4.02	1.92	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.49	2.66	1.23	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.09	3.83	1.21	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.34	2.97	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.80	2.16	0.96	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.12	1.88	1.18	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.15	3.22	0.73	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.08	2.95	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.89	3.32	1.40	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.04	3.01	1.61	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.49	1.86	0.47	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.51	2.88	0.48	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.33	1.79	0.30	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.60	5.03	0.48	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.92	4.45	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.48	4.30	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.12	5.56	1.56	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.71	5.32	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.26	4.31	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	1.68	0.00	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	1.38	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.67	4.86	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.49	6.42	0.32	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	3.14	0.63	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	3.53	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	3.36	0.56	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	0.80	0.80	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.76	3.40	0.34	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.77	2.60	0.32	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	5.32	0.00	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.99	1.95	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	2.98	0.50	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.14	2.81	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	0.99	0.66	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.27	3.40	1.55	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.10	3.06	1.53	3.67
Adipocyte - breast, donor1	11376-118A8	6.65	0.95	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	7.06	1.12	1.12	0.16
Adipocyte - omental, donor1	11473-119C6	7.63	1.40	0.38	0.64
Adipocyte - omental, donor2	11474-119C7	2.24	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	2.01	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	1.91	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	2.26	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.91	0.70	0.87	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	22.88	5.48	1.76	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	4.89	1.80	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	15.61	6.13	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	17.05	4.11	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	20.27	2.57	1.69	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	16.78	2.26	1.29	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	2.67	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	2.23	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	0.42	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	12.06	2.01	1.51	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	13.42	1.96	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	2.13	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	23.20	3.31	0.88	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	0.72	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	26.63	5.94	1.44	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	6.69	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.38	3.70	2.05	0.00
Anulus Pulposus Cell, donor1	11248-116E6	22.08	1.83	1.14	0.57
Anulus Pulposus Cell, donor2	11463-119B5	19.84	2.20	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	2.25	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.25	3.04	0.43	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.77	1.49	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.85	0.65	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	2.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	3.56	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	2.26	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	2.18	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.74	1.32	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	1.36	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.88	1.36	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.69	2.27	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.95	1.34	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.46	1.49	1.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.63	1.20	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	0.97	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	1.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.27	0.57	2.28	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.63	0.43	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.68	1.03	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	1.41	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	2.25	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	1.20	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.15	0.25	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.45	1.69	0.21	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.22	1.45	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	3.78	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.10	1.36	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.22	1.72	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	2.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.98	1.15	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.84	2.48	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	0.92	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.74	1.43	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.43	0.67	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	1.11	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.97	1.32	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	1.09	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	14.49	3.19	1.11	0.49
Astrocyte - cerebellum, donor2	11580-120F5	15.75	3.42	1.37	0.34
Astrocyte - cerebellum, donor3	11661-122F5	9.65	1.05	0.84	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	40.78	3.83	5.23	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	36.40	3.56	8.25	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	32.07	3.58	5.52	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	96.57	20.87	7.91	4.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	72.91	17.16	7.39	2.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	81.14	18.44	5.80	2.39
Basophils, donor1	12241-129G9	10.20	3.92	1.57	0.52
Basophils, donor2	12242-129H1	16.24	5.41	1.44	0.36
Basophils, donor3	12243-129H2	20.43	8.08	1.47	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	10.13	2.59	0.43	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	0.46	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	10.61	2.08	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	5.99	1.38	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	8.28	1.98	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.93	0.21	0.72	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	22.70	5.76	2.56	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	22.54	9.02	4.51	2.25
CD14+ Monocytes, donor2	11305-117B9	27.47	13.18	1.86	3.71
CD14+ Monocytes, donor3	11381-118B4	25.03	10.54	1.76	3.51
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	65.10	15.00	5.94	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	52.69	12.51	4.17	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	68.71	22.03	7.89	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	26.02	19.80	4.19	3.47
CD14+ monocytes - mock treated, donor2	11873-125C1	30.48	15.09	2.41	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	34.59	19.19	6.40	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.40	11.38	1.51	2.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.46	7.18	1.66	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	16.61	6.45	1.49	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.62	6.85	2.55	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.52	6.94	2.67	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.58	6.96	2.83	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.11	4.92	1.87	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.54	6.86	2.11	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	18.86	15.53	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.15	10.71	2.83	2.38
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.36	8.98	1.20	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.08	6.66	1.67	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.47	8.01	1.60	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.89	6.11	1.81	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.71	8.73	1.75	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.74	18.83	3.23	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.86	18.67	4.71	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	43.77	19.78	6.31	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.43	3.49	0.73	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	4.58	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	2.63	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.60	10.81	2.09	3.84
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	27.50	8.18	2.60	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	29.53	9.92	5.17	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	6.96	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.65	4.17	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.87	1.86	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	25.07	11.77	5.23	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	37.65	11.09	6.70	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	23.61	6.93	2.38	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	34.26	16.66	2.34	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	20.61	11.00	3.32	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	30.32	18.95	3.12	5.80
CD14-CD16+ Monocytes, donor1	11790-124B8	50.78	16.08	8.17	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	43.25	15.15	8.56	2.20
CD14-CD16+ Monocytes, donor3	11911-125G3	33.90	9.69	4.42	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	14.23	12.19	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.07	14.92	10.17	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	45.57	11.39	8.28	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	50.11	10.13	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	43.42	12.87	4.29	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	58.26	13.34	4.91	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.89	16.47	9.41	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	6.59	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	53.42	14.79	4.93	2.47
CD19+ B Cells, donor2	11624-122B4	31.19	11.61	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	30.29	8.08	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	16.57	2.83	0.81	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.99	2.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	11.04	5.02	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	11.24	0.56	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.30	7.14	3.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.00	10.60	3.83	0.00
CD4+ T Cells, donor1	11225-116C1	37.49	3.21	1.79	0.71
CD4+ T Cells, donor2	11306-117C1	17.15	1.84	1.84	2.45
CD4+ T Cells, donor3	11382-118B5	14.64	4.88	1.22	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	29.86	6.38	1.53	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	39.98	6.96	2.02	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.31	8.05	2.30	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	28.92	2.37	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	2.11	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.51	5.93	1.16	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	34.74	7.80	1.69	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	34.01	7.90	2.90	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.38	4.48	2.24	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	26.20	6.64	1.05	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	3.96	0.00	7.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.30	9.28	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.54	8.73	2.08	3.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.39	8.69	1.34	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	25.56	5.17	2.18	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	35.37	3.75	1.61	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	0.00	7.17	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	37.83	14.83	2.41	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.28	9.10	3.03	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	30.89	13.24	1.26	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.24	4.04	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	18.63	2.60	1.73	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.53	3.49	1.74	4.36
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.76	4.95	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	13.85	2.77	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	8.37	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	27.42	8.58	1.94	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	29.69	6.87	1.47	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	10.78	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	30.08	7.16	2.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	5.54	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	23.25	4.91	2.62	0.98
CD8+ T Cells, donor2	11307-117C2	27.41	3.75	1.50	1.13
CD8+ T Cells, donor3	11383-118B6	29.29	5.30	2.02	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.55	1.84	1.38	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.66	1.92	1.20	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.76	3.01	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.61	3.00	0.30	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.92	1.44	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.37	2.50	0.91	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.91	1.74	0.87	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.84	2.11	0.53	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.96	2.58	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.47	0.60	1.81	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.59	3.20	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.52	1.60	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	1.31	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.65	0.46	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	1.49	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.77	1.80	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.10	2.01	0.86	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.84	1.41	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.41	0.95	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.76	4.00	1.23	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	2.56	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.41	1.15	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.06	2.76	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	2.41	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	8.39	0.70	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	1.83	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	3.46	1.98	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	9.26	1.16	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	17.68	6.59	0.35	6.24
Chondrocyte - de diff, donor2	11338-117F6	10.66	2.13	1.42	0.36
Chondrocyte - de diff, donor3	11410-118E6	9.90	1.37	0.91	1.37
Chondrocyte - re diff, donor2	11339-117F7	20.59	7.16	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.98	2.02	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	16.98	4.25	1.95	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	10.90	2.14	1.50	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	13.72	2.48	1.42	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	32.74	5.87	3.94	0.73
Corneal Epithelial Cells, donor1	11526-119I5	13.83	3.29	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	14.79	3.41	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	13.55	4.09	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.32	9.08	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.35	5.05	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.12	5.51	0.76	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	72.09	6.49	12.30	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	48.31	5.22	11.10	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	52.75	5.81	11.13	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.18	5.00	1.83	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	2.35	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	17.53	5.37	2.55	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	13.37	4.33	1.97	0.39
Endothelial Cells - Artery, donor1	11264-116G4	11.34	2.62	1.45	0.29
Endothelial Cells - Artery, donor2	11341-117F9	13.65	1.65	1.88	0.24
Endothelial Cells - Artery, donor3	11413-118E9	15.78	4.38	2.10	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.85	2.88	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	3.35	2.13	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.53	4.51	1.41	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	15.15	3.27	2.08	2.97
Endothelial Cells - Microvascular, donor2	11342-117G1	11.98	1.56	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	23.82	4.68	2.55	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	14.00	2.00	4.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	10.48	3.14	2.10	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	33.92	7.83	6.09	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	22.16	6.95	2.82	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.28	7.08	3.30	0.24
Endothelial Cells - Vein, donor1	11267-116G7	10.24	3.41	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	13.27	6.29	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.64	4.55	1.57	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.46	3.42	0.00	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	2.87	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.26	0.99	0.11	2.19
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.58	1.63	0.33	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.31	2.79	1.33	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.29	2.05	1.36	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.71	2.64	0.74	2.85
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	25.03	2.90	1.32	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.60	2.66	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	14.52	2.27	1.81	0.45
Fibroblast - Cardiac, donor2	11345-117G4	9.85	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	8.83	1.26	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	27.58	5.46	2.12	0.61
Fibroblast - Cardiac, donor5	11456-119A7	12.06	2.28	0.51	0.25
Fibroblast - Cardiac, donor6	11460-119B2	11.22	2.27	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.75	3.35	1.07	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.90	1.73	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	38.52	1.15	2.31	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	14.25	3.73	1.36	0.34
Fibroblast - Dermal, donor1	11269-116G9	28.88	1.64	1.64	0.70
Fibroblast - Dermal, donor2	11346-117G5	30.66	1.89	1.89	0.47
Fibroblast - Dermal, donor3	11418-118F5	33.61	1.93	2.54	3.14
Fibroblast - Dermal, donor4	11450-119A1	36.97	4.07	2.71	0.79
Fibroblast - Dermal, donor5	11454-119A5	35.41	4.01	2.62	2.79
Fibroblast - Dermal, donor6	11458-119A9	43.20	4.87	3.57	3.41
Fibroblast - Gingival, donor1	11237-116D4	40.81	3.33	3.75	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.67	4.19	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	25.83	3.43	2.50	0.66
Fibroblast - Gingival, donor3	11394-118C8	45.06	4.83	3.38	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	2.08	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.92	1.94	1.23	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.27	2.81	1.87	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.64	3.65	1.76	1.89
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.11	3.53	4.23	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.74	2.34	1.17	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.14	2.18	0.68	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.18	3.07	1.32	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.21	3.52	0.73	0.29
Fibroblast - Lung, donor1	11270-116H1	20.39	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	2.98	2.98	4.48
Fibroblast - Lung, donor3	11419-118F6	19.42	1.48	1.90	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	74.97	13.33	3.33	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.75	0.84	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	70.64	4.47	4.06	0.41
Fibroblast - Mammary, donor2	11620-122A9	31.95	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.36	3.30	3.10	2.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.50	5.46	5.01	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	79.56	7.96	7.96	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.32	3.05	2.29	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.96	1.08	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.64	1.74	0.70	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.95	1.22	0.88	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	65.22	4.88	4.27	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	47.44	4.01	4.01	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.91	2.37	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	27.78	5.16	3.37	3.37
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	13.50	1.07	0.36	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.75	2.56	0.39	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.47	4.21	2.11	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.08	2.59	0.65	3.13
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.25	2.02	1.01	3.54
Fibroblast - skin normal, donor1	11553-120C5	14.27	1.48	1.15	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	33.69	5.01	3.21	1.40
Fibroblast - skin normal, donor2	11561-120D4	9.04	2.01	0.50	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.41	7.25	0.60	5.44
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.42	2.57	0.58	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.02	2.74	1.20	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	19.71	3.28	0.99	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.10	2.02	1.07	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	23.11	1.35	1.35	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.86	0.31	0.63	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	2.61	1.74	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.91	3.81	1.21	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.53	1.04	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.29	3.07	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	17.61	1.53	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.21	2.55	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	11.98	3.14	4.56	3.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.51	4.96	1.93	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	13.24	3.88	1.37	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.66	2.18	4.16	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.95	3.70	2.11	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.13	4.57	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.82	2.21	1.33	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.42	5.51	3.82	2.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.03	5.05	3.32	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	3.22	1.61	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.22	2.23	2.60	1.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	17.86	4.01	3.18	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.64	1.83	3.46	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.20	3.88	2.28	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	14.20	4.48	1.87	2.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.92	2.62	2.19	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.30	4.73	1.77	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.26	3.50	2.07	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.76	2.23	1.12	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.20	4.44	2.42	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.76	3.22	3.22	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.32	6.03	2.22	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.76	6.35	4.27	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.40	5.46	4.44	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.93	3.76	2.77	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.55	3.83	3.00	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.54	3.47	3.27	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.66	2.48	2.27	2.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.91	4.04	3.46	2.77
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.01	3.00	2.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.74	3.09	3.31	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.94	3.07	2.83	2.71
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.61	3.40	3.08	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.92	5.13	2.25	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	15.44	3.70	2.75	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.09	3.16	4.59	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.03	3.65	3.65	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.46	4.70	2.61	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.78	3.95	3.51	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.08	4.49	3.09	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	12.59	4.07	2.22	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.17	2.94	1.60	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.15	3.21	2.30	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.34	3.37	1.42	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	16.81	1.90	1.36	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.20	2.95	1.47	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.96	4.39	2.19	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	68.43	10.91	2.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.82	4.09	2.37	2.64
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.79	2.42	1.82	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	89.72	14.23	8.13	4.83
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	19.11	2.39	2.39	5.57
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.57	4.47	3.70	4.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.85	7.36	6.14	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.46	3.13	3.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.30	2.26	3.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.84	6.00	4.15	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	4.95	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.06	2.32	4.25	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	1.74	12.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.34	2.93	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.94	2.47	4.12	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.02	3.08	3.36	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.77	1.31	1.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.94	4.19	3.36	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.09	2.23	4.13	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	10.53	2.04	3.06	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.74	2.86	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.81	2.66	1.78	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	1.69	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.67	2.49	2.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.34	2.53	4.14	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.53	1.54	3.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.50	1.30	2.28	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	10.40	3.08	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	15.41	1.71	3.77	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.97	2.83	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	8.45	3.62	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.84	3.56	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.16	1.99	4.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	11.35	2.96	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	5.90	4.72	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	1.75	2.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.09	1.32	2.63	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	2.54	4.24	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	18.50	3.58	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	2.91	2.43	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.39	1.66	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	2.25	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.32	1.27	0.00	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.10	2.09	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.39	2.44	1.51	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.36	3.21	1.86	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.97	1.59	1.82	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.10	2.08	2.19	1.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	14.18	2.36	1.07	2.58
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.84	2.37	1.08	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.47	1.25	0.87	1.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	1.37	1.72	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	1.60	1.28	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	22.38	1.12	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	2.60	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.87	2.12	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	2.18	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.20	1.22	0.00	1.05
Hepatocyte, donor1	11523-119I2	53.27	3.63	2.42	7.26
Hepatocyte, donor2	11603-120I1	45.25	5.39	3.23	2.15
Hepatocyte, donor3	11684-122I1	22.70	2.45	4.91	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	18.28	2.61	7.18	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.40	6.12	3.15	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	9.74	1.10	0.69	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	9.55	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	30.46	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	5.01	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	5.13	7.69	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	5.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	11.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	5.54	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	6.93	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	4.64	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.32	9.04	2.58	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	6.44	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	21.19	6.52	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.19	5.46	3.78	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.90	8.04	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	3.69	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	6.14	2.36	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	3.63	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	5.38	4.30	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	25.41	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	7.65	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	14.28	6.43	4.28	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.05	5.86	2.16	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	7.02	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	6.95	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	10.46	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	8.53	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	2.77	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	6.44	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	8.46	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.94	1.22	0.49	0.00
Keratinocyte - epidermal, donor2	11349-117G8	5.27	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.40	1.42	0.19	0.38
Keratinocyte - oral, donor1	11251-116E9	24.29	4.09	1.70	3.86
Keratocytes, donor1	11527-119I6	39.20	1.03	2.41	0.00
Keratocytes, donor2	11607-120I5	22.26	2.34	0.00	1.17
Keratocytes, donor3	11688-122I5	11.66	1.38	0.20	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	4.40	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	8.63	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	19.26	2.08	1.38	0.81
Lens Epithelial Cells, donor3	11690-122I7	8.58	1.51	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.98	2.73	0.59	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	3.07	1.40	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.93	2.36	0.79	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	2.15	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.45	2.52	0.63	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.79	3.67	0.97	1.83
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	3.28	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	1.77	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.30	3.94	1.13	2.11
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.31	0.79	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	0.97	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.74	2.04	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	2.44	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.20	1.91	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.87	2.61	0.96	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.85	1.23	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.05	1.87	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.52	4.76	1.28	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.22	1.32	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	2.64	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.97	3.24	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	3.88	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.08	2.96	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.51	3.33	1.06	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	2.59	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.49	2.09	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.86	2.26	0.90	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	2.06	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.53	2.45	0.94	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.27	2.86	0.53	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.27	2.91	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	1.98	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.57	3.22	1.24	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.22	1.48	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	1.24	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.77	2.75	0.27	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	1.93	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.96	3.35	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.00	2.38	1.26	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	3.20	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	0.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.85	2.33	0.93	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	1.79	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.15	1.96	1.63	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	1.41	1.18	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.13	3.47	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	1.02	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.48	1.49	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	3.07	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	5.20	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	1.69	1.27	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	2.81	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	0.00	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.73	2.06	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	4.76	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.54	4.75	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	11.34	4.36	2.33	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	6.30	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.70	7.05	1.90	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.27	4.11	1.54	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	3.53	2.12	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	8.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	4.08	2.55	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.94	2.93	1.60	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.42	5.48	1.89	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	2.45	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	5.71	4.89	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.45	2.50	2.08	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.05	4.76	1.68	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	5.15	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.61	4.64	1.74	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.36	2.99	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	2.21	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.61	6.01	2.47	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.54	4.43	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	3.45	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	6.52	2.30	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.06	1.70	3.96	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	7.38	3.28	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	6.78	3.16	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	5.03	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	3.73	2.24	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.81	7.43	2.60	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.78	3.88	0.86	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	5.14	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.99	3.00	3.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	4.83	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	4.27	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.72	4.81	2.41	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	6.44	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	2.02	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.85	4.82	3.70	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	3.49	5.81	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	6.35	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.61	5.60	2.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	2.91	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	22.23	3.07	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	5.92	3.95	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	4.70	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	18.10	5.03	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.62	3.15	2.25	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.04	3.56	3.12	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.51	7.04	2.74	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	1.98	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	6.23	2.08	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.25	3.50	2.63	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	3.35	2.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.52	4.86	4.86	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.81	6.17	2.70	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	4.56	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.46	3.84	3.36	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.52	6.76	1.99	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.19	3.65	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	8.30	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.52	7.22	3.04	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	4.13	5.16	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	6.05	6.05	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.70	4.12	1.27	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	6.93	4.26	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.11	5.17	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	6.69	2.57	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	23.34	5.66	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.83	6.24	5.11	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	25.79	4.99	2.91	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	5.48	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	26.72	5.43	4.18	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.37	5.58	5.11	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	5.35	4.68	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	4.28	4.81	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.69	4.85	2.83	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	5.51	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.90	5.33	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.33	6.27	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	10.74	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.89	7.66	1.64	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	41.43	6.24	5.79	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.70	6.76	2.86	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.90	7.96	1.99	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	45.58	10.71	3.42	0.46
Macrophage - monocyte derived, donor2	11313-117C8	13.58	4.04	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	27.40	9.44	1.70	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	3.19	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	8.40	1.43	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	7.09	2.22	0.42	0.56
Mammary Epithelial Cell, donor1	11273-116H4	8.77	0.90	0.40	1.79
Mammary Epithelial Cell, donor2	11350-117G9	7.24	2.32	0.58	1.74
Mammary Epithelial Cell, donor3	11422-118F9	7.73	1.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	9.49	2.71	0.00	0.68
Mast cell, donor1	11563-120D6	23.57	10.71	1.51	0.65
Mast cell, donor2	11565-120D8	50.52	21.69	7.43	5.05
Mast cell, donor3	11566-120D9	46.15	26.79	4.95	3.15
Mast cell, donor4	11567-120E1	61.34	30.67	9.93	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	37.59	14.31	2.66	5.77
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	10.51	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	40.15	16.98	3.44	1.95
Mast cell, expanded, donor8	11941-126A6	28.79	22.26	2.51	1.17
Melanocyte - dark, donor1	11502-119F8	10.15	1.89	1.59	0.60
Melanocyte - dark, donor2	11582-120F7	5.19	0.69	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	6.16	1.16	0.51	0.43
Melanocyte - light, donor1	11274-116H5	6.11	1.65	1.18	0.00
Melanocyte - light, donor2	11351-117H1	10.24	2.73	1.36	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.95	3.12	2.60	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	22.05	3.50	4.03	3.23
Melanocyte, donor3 (MC+3)	12837-137B2	13.39	1.61	1.87	1.07
Meningeal Cells, donor1	11493-119E8	33.74	6.45	3.97	0.74
Meningeal Cells, donor2	11573-120E7	19.81	3.96	2.20	0.00
Meningeal Cells, donor3	11654-122E7	21.76	3.83	1.22	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.53	2.57	2.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.45	1.41	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	1.31	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.94	2.87	4.31	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.13	0.85	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.06	2.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.47	3.08	1.76	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	47.49	6.58	3.65	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.28	4.30	4.09	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.19	1.52	0.55	2.22
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.75	0.74	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.05	3.03	0.92	2.37
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.15	0.89	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	3.84	1.92	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	19.85	1.77	0.71	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.20	0.63	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.55	2.65	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	2.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.28	2.24	0.58	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.02	7.63	2.22	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.26	5.59	0.88	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.91	3.10	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.80	4.15	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.53	5.01	3.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.93	7.45	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	30.08	5.08	1.02	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.84	2.77	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	4.42	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.44	3.04	0.76	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	7.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.28	3.82	2.33	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.50	4.47	1.19	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.29	2.51	1.51	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.78	2.14	0.71	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	2.21	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	1.38	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.19	4.42	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.49	1.02	0.20	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	2.15	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.67	2.45	1.11	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.83	1.75	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	4.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	1.63	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.23	3.53	1.47	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	1.09	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.42	1.92	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	23.61	4.80	2.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	4.11	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	3.50	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.40	2.19	3.50	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	3.31	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	25.62	4.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	26.53	3.97	1.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.92	4.87	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	27.35	5.13	0.68	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.44	4.81	0.88	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	18.11	3.91	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	26.93	4.77	0.84	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.61	2.08	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	14.57	3.50	2.91	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	5.13	1.51	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	18.78	3.34	1.67	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.94	4.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.20	6.26	2.28	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.83	4.70	1.38	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.66	1.81	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.88	6.43	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	1.91	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.42	2.67	1.60	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.04	5.39	0.90	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.92	5.51	1.27	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	2.55	1.27	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	23.66	2.65	2.43	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.55	5.31	1.14	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.74	5.11	1.70	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.32	5.90	1.72	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	4.56	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.11	4.70	2.06	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.97	7.21	1.15	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.14	6.59	1.65	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.74	7.44	1.79	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	44.69	5.91	4.60	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	1.05	2.10	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	33.41	4.94	2.17	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	6.52	0.93	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.43	6.01	2.63	4.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.97	4.79	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.33	3.73	2.49	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	29.47	2.95	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.54	3.66	2.56	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	4.67	3.11	26.45
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	1.60	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	4.04	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.69	0.84	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	1.51	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.41	2.59	1.29	3.88
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	2.09	2.61	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	1.33	4.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.77	0.83	2.09	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.98	0.57	1.71	3.80
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	3.40	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	1.84	1.84	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	2.93	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.50	2.32	1.39	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	24.59	3.24	1.35	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.00	3.99	2.94	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	2.98	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.01	1.62	0.81	1.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.73	1.36	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.94	2.78	0.82	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.33	3.65	1.09	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.57	2.12	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	1.80	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.24	0.33	1.31	4.92
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.92	1.46	0.49	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.28	4.76	3.88	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	1.41	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.60	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.75	1.93	2.25	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.17	0.34	1.03	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	2.53	0.00	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.50	3.56	1.11	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.16	1.27	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	2.14	0.95	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.88	1.72	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	2.33	1.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	1.35	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	3.17	1.19	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.70	1.51	1.14	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	1.63	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	4.36	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	2.71	2.26	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	1.33	0.66	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	1.53	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.01	0.91	0.91	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.04	1.99	0.66	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	1.36	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	1.26	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	0.91	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	15.17
Myoblast, donor1	11241-116D8	17.14	0.87	0.62	0.50
Myoblast, donor2	11322-117D8	20.90	1.53	0.77	1.73
Myoblast, donor3	11398-118D3	23.54	2.69	2.52	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	22.47	11.24	2.04	1.46
Natural Killer Cells, donor1	11230-116C6	25.22	11.69	2.46	1.23
Natural Killer Cells, donor2	11311-117C6	21.41	8.75	0.90	2.41
Natural Killer Cells, donor3	11387-118C1	24.30	8.47	3.13	2.21
Neural stem cells, donor1	11275-116H6	45.73	6.53	3.99	1.81
Neural stem cells, donor2	11352-117H2	32.74	1.93	9.63	1.93
Neurons, donor1	11494-119E9	23.90	3.41	5.69	4.55
Neurons, donor2	11574-120E8	15.85	1.98	2.86	1.10
Neurons, donor3	11655-122E8	24.66	1.64	3.29	0.82
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	4.28	2.44	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.98	3.32	0.95	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	15.63	3.58	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	21.46	1.60	1.80	1.00
Olfactory epithelial cells, donor1	11933-125I7	11.01	1.79	0.28	1.10
Olfactory epithelial cells, donor2	11934-125I8	12.30	2.03	0.43	1.88
Olfactory epithelial cells, donor3	11935-125I9	9.31	1.59	0.68	0.91
Olfactory epithelial cells, donor4	11936-126A1	11.69	2.05	0.97	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	28.89	4.81	0.60	3.61
Osteoblast - differentiated, donor1	11276-116H7	11.49	2.13	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	3.43	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	1.86	0.62	1.24
Osteoblast, donor1	11277-116H8	13.68	3.13	0.78	0.78
Osteoblast, donor2	11354-117H4	19.66	5.62	1.40	1.40
Osteoblast, donor3	11426-118G4	17.42	2.67	1.96	0.18
Pancreatic stromal cells, donor1	11249-116E7	23.25	2.86	1.26	1.43
Pericytes, donor1	11491-119E6	17.47	1.45	0.78	0.22
Pericytes, donor2	11571-120E5	12.22	2.94	2.26	0.68
Pericytes, donor3	11652-122E5	21.77	2.03	1.22	0.20
Perineurial Cells, donor1	11499-119F5	21.36	1.92	1.92	0.68
Perineurial Cells, donor2	11579-120F4	8.65	1.47	0.46	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	15.94	4.14	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.98	13.22	2.69	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	29.64	9.71	3.62	1.55
Placental Epithelial Cells, donor1	11278-116H9	7.65	1.67	1.20	0.96
Placental Epithelial Cells, donor2	11355-117H5	7.76	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.90	1.96	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.16	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	5.82	1.88	0.00	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.36	2.09	0.52	0.13
Preadipocyte - breast, donor2	11328-117E5	6.08	0.68	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	9.27	2.24	0.53	0.43
Preadipocyte - omental, donor2	11329-117E6	7.42	3.93	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	7.45	1.00	0.57	0.14
Preadipocyte - perirenal, donor1	11469-119C2	5.91	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.05	1.54	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	24.44	2.12	1.77	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	11.07	1.87	1.02	0.85
Preadipocyte - visceral, donor1	11280-116I2	29.34	3.91	0.84	1.02
Preadipocyte - visceral, donor2	11357-117H7	13.81	0.92	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	17.14	1.78	1.15	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.24	6.49	5.13	1.06
Prostate Epithelial Cells, donor2	11331-117E8	6.09	1.35	0.14	0.41
Prostate Epithelial Cells, donor3	11404-118D9	8.51	1.29	0.67	0.67
Prostate Stromal Cells, donor1	11254-116F3	17.54	0.80	1.14	0.46
Prostate Stromal Cells, donor2	11332-117E9	21.70	2.33	2.15	2.15
Prostate Stromal Cells, donor3	11405-118E1	15.64	2.82	0.94	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.96	3.28	1.82	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.06	3.74	0.83	2.29
Renal Epithelial Cells, donor1	11517-119H5	21.30	5.07	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	15.65	2.85	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	18.10	3.39	0.53	4.45
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	2.04	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.07	3.10	0.94	1.48
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.98	3.33	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	2.66	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.99	4.62	1.98	1.10
Renal Mesangial Cells, donor2	11598-120H5	23.20	6.27	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.31	4.44	1.11	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.37	2.95	0.81	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	0.42	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.55	3.47	1.35	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.85	1.56	2.59	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.49	4.26	1.71	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.03	2.01	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	60.94	8.02	9.76	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	5.36	2.68	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.67	7.15	2.75	8.26
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	12.18	6.96	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.10	5.85	2.60	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	28.00	6.75	4.27	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.11	6.92	5.69	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.61	3.97	4.47	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.62	5.48	3.50	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.58	8.78	5.32	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.29	4.11	3.01	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.51	4.84	4.99	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.09	4.30	3.05	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.24	5.16	2.30	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.93	4.61	4.19	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.65	7.08	3.98	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.66	4.01	1.53	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.97	5.59	2.79	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.57	10.33	4.13	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.76	5.57	3.05	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.74	7.50	3.60	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.35	7.64	4.58	5.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.32	5.34	2.88	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.63	5.33	4.48	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.25	7.52	3.25	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.89	5.11	2.01	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	25.02	4.66	4.17	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	22.97	5.24	5.10	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	24.53	4.95	3.07	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.61	5.56	3.17	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.42	7.48	6.55	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.71	6.84	3.32	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.56	3.98	1.99	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.00	8.56	5.22	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	31.49	5.11	2.56	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.50	5.45	3.58	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.40	8.68	6.17	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.60	7.74	1.89	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.32	7.41	2.74	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.07	5.42	3.94	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.71	5.97	2.56	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.63	4.73	5.33	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	45.58	5.06	6.40	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.98	6.50	2.07	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.71	5.48	3.81	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	56.83	13.91	6.25	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	24.30	5.74	3.86	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	29.70	8.38	3.49	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.94	9.37	3.63	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.27	6.49	2.57	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	60.55	17.90	10.48	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	32.86	4.87	4.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	30.14	3.62	4.22	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	33.02	8.82	6.33	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.93	12.28	6.89	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.91	8.03	4.49	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.96	12.38	4.48	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.26	15.02	7.81	1.80
Schwann Cells, donor1	11498-119F4	11.10	1.32	0.94	0.56
Schwann Cells, donor2	11578-120F3	20.41	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.36	2.85	1.53	0.66
Sebocyte, donor1	11220-116B5	13.69	3.83	0.55	0.00
Sebocyte, donor2	11301-117B5	14.71	0.92	0.92	0.00
Sebocyte, donor3	11378-118B1	17.73	2.68	0.62	0.21
Sertoli Cells, donor1	11255-116F4	3.31	6.63	3.31	0.00
Sertoli Cells, donor2	11333-117F1	8.47	5.65	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	18.74	2.73	2.20	2.20
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	17.56	8.36	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.57	2.51	1.26	0.31
Skeletal Muscle Cells, donor5	11455-119A6	14.72	1.49	0.59	0.74
Skeletal Muscle Cells, donor6	11459-119B1	21.24	1.69	0.62	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.37	2.90	0.88	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.98	4.42	1.57	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.22	3.17	1.88	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.50	3.20	1.52	1.43
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.88	2.17	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.36	3.03	1.38	0.00
Skin - palm, donor1	10286-104F7	10.74	18.80	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.93	0.43	0.14	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	29.44	1.64	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.22	2.73	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.95	0.97	0.42	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	16.88	2.39	0.98	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	40.60	7.40	1.90	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	18.14	4.35	1.65	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.17	0.62	0.31	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.56	1.56	1.56	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.41	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.76	2.65	1.33	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	14.57	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	2.32	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.31	2.66	0.53	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.19	2.22	1.11	2.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.94	2.05	0.64	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.12	1.30	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.54	1.18	1.77	2.07
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.55	1.00	1.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.73	2.60	1.79	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.35	0.91	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.67	1.77	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	18.36	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	2.86	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.18	1.03	0.88	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.82	1.29	1.08	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.01	2.83	0.94	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.77	2.78	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	3.23	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.28	2.39	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.85	2.05	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.63	2.51	1.49	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.88	6.94	2.42	2.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	3.19	2.28	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.75	2.38	1.59	2.91
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.45	2.00	0.93	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	21.91	4.63	2.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.22	2.03	1.27	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.34	1.96	1.36	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	3.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	63.32	9.05	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	2.79	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	2.52	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.27	1.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	14.16	2.06	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	27.91	3.67	2.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.09	3.27	0.00	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.37	1.58	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.26	3.06	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.27	3.01	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.18	1.54	1.26	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.88	1.26	0.50	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.10	0.98	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	10.61	3.09	0.66	4.42
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.24	1.17	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.52	1.17	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.64	1.06	1.32	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	1.12	0.74	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.89	1.44	2.52	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.78	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.15	1.18	0.79	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	6.86	2.29	0.25	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	0.80	0.40	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	0.42	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	0.46	0.46	0.92
Synoviocyte, donor1	11291-117A4	41.74	3.37	3.70	3.87
Synoviocyte, donor2	11368-117I9	13.41	2.35	1.01	0.84
Synoviocyte, donor3	11440-118H9	10.95	2.68	0.89	2.68
Trabecular Meshwork Cells, donor1	11532-120A2	45.02	5.36	3.22	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	33.81	1.85	3.70	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	11.25	0.93	0.57	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	5.80	1.55	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	2.29	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	60.04	5.78	8.73	0.86
Urethra, donor2	10319-105A4	16.19	12.59	1.80	12.59
Urothelial Cells, donor1	11520-119H8	13.81	1.86	0.80	0.53
Urothelial Cells, donor2	11600-120H7	7.61	4.81	0.00	0.00
Urothelial Cells, donor3	11681-122H7	11.00	2.75	0.23	0.23
Urothelial cells, donor0	11216-116B1	14.49	4.24	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	18.69	6.23	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	12.87	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	24.64	6.85	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.55	7.23	1.38	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	7.55	2.91	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	11.45	9.37	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	26.62	11.01	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	4.56	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	20.11	6.17	2.34	2.47
Wilms' tumor cell line:HFWT	10597-108E3	17.60	7.04	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.89	5.87	0.56	0.56
achilles tendon, donor2	10292-104G4	28.93	6.20	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	54.05	14.28	9.18	7.14
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.72	6.73	1.86	3.48
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.47	5.82	5.22	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.47	4.08	3.27	7.07
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.19	11.81	6.46	9.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	22.84	10.36	2.54	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	21.50	6.53	4.36	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.03	6.17	4.41	6.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.02	10.62	6.53	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	80.38	26.40	16.31	8.93
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	12.14	7.54	2.21	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	19.50	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	25.79	13.25	3.49	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.44	10.61	2.85	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.38	11.69	3.80	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	25.56	9.76	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.56	10.28	3.70	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	5.22	0.92	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.37	9.81	2.13	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	17.89	9.10	2.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	22.63	8.91	1.93	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	19.38	4.68	2.00	3.79
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	12.43	2.64	1.13	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.45	14.39	5.67	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	42.63	16.48	1.18	2.35
adipose tissue, adult, pool1	10010-101C1	24.66	5.58	2.02	1.40
adipose, donor1	10184-103D4	6.45	2.35	0.59	0.59
adipose, donor2	10185-103D5	8.11	2.43	1.22	0.41
adipose, donor3	10186-103D6	7.62	5.72	1.36	2.45
adipose, donor4	10187-103D7	15.60	8.67	0.87	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	11.52	3.00	1.58	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	3.64	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	65.50	12.54	6.94	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.72	6.07	1.07	5.00
amniotic membrane cells, donor1	12235-129G3	11.13	2.78	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	15.21	4.06	2.37	0.68
amniotic membrane cells, donor3	12237-129G5	7.66	1.77	1.47	0.00
amygdala - adult, donor10196	10167-103B5	7.11	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	14.40	1.42	2.03	0.61
amygdala, newborn, donor10223	10360-105E9	11.30	0.65	1.61	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	18.46	3.06	2.29	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	58.69	4.85	13.90	6.40
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	32.74	9.35	8.35	1.34
aorta, adult, pool1	10052-101G7	49.62	6.28	3.92	4.90
appendix, adult	10189-103D9	35.32	15.14	4.27	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.01	5.16	1.03	1.38
artery, adult	10190-103E1	24.46	6.79	8.15	1.36
astrocytoma cell line:TM-31	10425-106D2	27.81	6.52	3.62	0.29
b cell line:RPMI1788	10427-106D4	67.96	14.28	6.10	7.73
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.65	1.66	0.28	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.92	7.05	1.89	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	75.15	13.56	13.06	7.03
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	11.18	6.71	2.80	1.12
bladder, adult, pool1	10011-101C2	26.83	4.56	2.82	0.43
blood, adult, pool1	10053-101G8	13.29	6.64	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	5.14	1.71	1.71
bone marrow, adult	10192-103E3	29.02	4.05	4.05	14.17
brain, adult, donor1	10084-102B3	12.30	2.05	1.03	1.03
brain, adult, pool1	10012-101C3	5.68	0.89	0.56	0.33
brain, fetal, pool1	10085-102B4	10.69	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.87	2.64	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	30.58	5.87	6.49	0.62
breast, adult, donor1	10080-102A8	23.99	3.16	3.16	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.24	7.50	1.02	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	8.35	4.33	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	48.81	4.14	3.68	3.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	2.18	1.21	0.73
carcinoid cell line:NCI-H1770	10703-109H1	8.46	3.76	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	20.78	7.22	3.06	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	29.15	2.85	4.75	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.62	8.78	2.93	1.86
caudate nucleus - adult, donor10196	10177-103C6	23.03	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	16.23	2.34	2.68	0.00
caudate nucleus, adult, donor10258	10379-105H1	9.93	0.00	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	28.20	5.13	2.93	0.37
cerebellum - adult, donor10196	10173-103C2	17.48	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	7.26	0.43	0.64	0.00
cerebellum, adult, pool1	10083-102B2	2.76	0.34	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	9.96	1.66	1.66	1.66
cerebral meninges, adult	10188-103D8	3.03	0.25	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	8.77	1.46	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	17.40	3.02	0.72	1.01
cervical cancer cell line:ME-180	10553-107I4	18.56	2.82	0.50	1.66
cervix, adult, pool1	10013-101C4	24.15	8.40	2.73	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	4.60	1.25	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	1.31	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	27.96	9.32	6.21	2.98
choriocarcinoma cell line:SCH	10785-110H2	17.74	3.70	3.33	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	20.87	5.22	4.03	0.24
chorionic membrane cells, donor1	12238-129G6	4.56	1.42	1.71	0.00
chorionic membrane cells, donor2	12239-129G7	14.91	2.29	2.39	0.80
chorionic membrane cells, donor3	12240-129G8	2.75	2.20	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	11.11	2.02	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.62	8.45	3.27	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.67	5.28	1.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.99	10.53	1.80	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.44	11.85	1.69	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.41	6.11	0.81	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	26.50	7.95	1.18	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.45	8.60	7.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.46	1.14	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	6.07	2.26	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	16.66	4.94	1.65	0.37
colon carcinoma cell line:COLO-320	10420-106C6	29.65	5.70	6.08	2.66
colon, adult, donor1	10082-102B1	51.17	16.66	3.57	5.95
colon, adult, pool1	10014-101C5	19.86	9.75	2.94	0.00
colon, fetal, donor1	10070-101I7	17.30	8.65	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	114.59	55.00	27.50	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	7.65	2.97	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.68	3.92	1.36	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	19.32	5.78	0.99	0.71
corpus callosum, adult, pool1	10042-101F6	26.65	3.87	2.54	0.66
cruciate ligament, donor2	10295-104G7	23.50	2.43	5.67	10.54
diaphragm, fetal, donor1	10069-101I6	32.91	5.62	3.21	0.80
diencephalon, adult	10193-103E4	4.08	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.84	10.33	1.61	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.77	6.15	2.82	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.17	2.17	2.65	3.61
ductus deferens, adult	10196-103E7	30.40	6.98	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	2.88	4.32	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	8.09	7.36	2.21
dura mater, adult, donor1	10041-101F5	37.99	10.98	3.06	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.99	2.44	4.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	19.34	2.44	3.01	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	3.70	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	18.47	4.24	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.98	8.03	0.93	0.62
embryonic pancreas cell line:2C6	10603-108E9	18.39	17.08	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	20.11	4.02	3.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	110.92	9.97	16.85	8.70
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.12	2.09	0.96	2.25
epidermoid carcinoma cell line:A431	10426-106D3	12.89	2.78	0.44	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.22	4.29	2.20	0.11
epididymis, adult	10197-103E8	23.23	9.21	1.47	2.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	21.11	3.55	3.02	3.19
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.82	2.36	7.47	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.98	5.64	4.85	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.96	9.25	5.61	3.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.14	5.49	3.92	1.57
esophagus, adult, pool1	10015-101C6	20.07	4.46	2.44	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	59.86	8.77	6.39	0.88
eye - muscle inferior rectus, donor1	10272-104E2	41.05	19.32	0.00	24.15
eye - muscle lateral, donor2	10298-104H1	6.31	6.31	4.21	4.21
eye - muscle medial, donor2	10299-104H2	32.74	2.98	1.49	4.46
eye - muscle superior, donor2	10297-104G9	47.01	8.03	6.88	6.88
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	18.56	2.03	2.80	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	18.34	4.10	1.67	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.52	3.56	2.61	0.95
frontal lobe, adult, pool1	10040-101F4	8.73	1.03	1.41	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.21	10.21	1.80	4.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.17	5.30	0.64	0.18
gall bladder, adult	10198-103E9	22.69	5.55	3.62	0.00
gamma delta positive T cells, donor1	11937-126A2	34.90	5.37	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	27.64	13.45	2.24	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.24	2.32	0.84	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.58	9.67	3.87	2.90
gastric cancer cell line:AZ521	10549-107H9	18.53	3.44	1.97	0.66
gastric cancer cell line:GSS	10560-108A2	67.73	5.49	10.07	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	11.88	3.20	4.11	0.00
giant cell carcinoma cell line:LU65	10487-107B1	8.95	1.15	0.80	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	36.53	3.64	4.06	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.20	4.99	1.00	2.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.93	3.48	1.90	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.50	2.39	1.40	0.56
glioblastoma cell line:T98G	10485-107A8	12.25	2.32	0.88	1.10
glioma cell line:GI-1	10413-106B8	12.59	3.22	0.88	1.76
globus pallidus - adult, donor10196	10175-103C4	17.49	4.37	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	17.57	2.20	1.71	0.98
globus pallidus, adult, donor10258	10367-105F7	6.85	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	12.79	2.66	3.73	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	200.67	63.63	24.47	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	15.68	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	15.68	2.56	0.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	18.36	4.13	4.13	0.92
hIPS +CCl2, biol_rep2	14384-156C1	19.66	1.83	1.37	1.37
hIPS +CCl2, biol_rep3	14385-156C2	15.46	3.86	1.29	1.29
hIPS, biol_rep1	14380-156B6	17.25	2.87	1.44	0.00
hIPS, biol_rep2	14381-156B7	15.77	2.06	3.43	3.43
hIPS, biol_rep3	14382-156B8	5.52	1.10	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	21.26	7.18	2.30	4.31
heart - mitral valve, adult	10205-103F7	21.23	5.38	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	63.28	9.67	7.58	11.77
heart - tricuspid valve, adult	10207-103F9	19.98	2.50	0.83	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	31.63	4.90	2.24	0.82
heart, adult, diseased, donor1	10051-101G6	40.88	5.54	2.98	6.39
heart, adult, pool1	10016-101C7	27.14	2.30	1.84	0.00
heart, fetal, pool1	10046-101G1	81.73	9.34	9.34	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	3.09	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	4.76	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.23	5.64	3.20	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.51	4.61	5.46	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	23.04	6.57	5.25	0.20
hepatoma cell line:Li-7	10484-107A7	26.91	2.00	3.78	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.58	6.43	3.42	2.71
hippocampus - adult, donor10196	10169-103B7	6.62	0.00	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	19.19	1.43	2.65	0.61
hippocampus, adult, donor10258	10374-105G5	5.98	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	10.22	0.35	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.21	2.44	3.66	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.71	4.12	1.96	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.01	4.06	3.81	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	6.20	3.38	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.36	3.36	2.84	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	10.63	5.31	4.18	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.34	4.67	0.88	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.48	4.74	2.80	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	4.17	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8.05	2.84	0.95	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.77	4.50	1.13	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.12	2.02	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.84	3.44	2.50	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.21	1.97	3.93	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	3.49	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	12.98	4.58	1.15	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	11.77	4.80	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	7.50	4.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.67	4.71	0.94	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	5.46	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	10.34	2.82	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.17	4.90	1.14	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.29	2.90	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	6.28	3.59	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.37	4.25	3.14	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.41	2.57	2.00	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	15.11	2.45	3.67	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.14	3.52	0.35	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.82	4.43	2.22	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.68	1.82	1.51	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.00	4.14	0.00	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	3.32	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.72	3.08	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.44	5.37	1.02	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	10.60	6.06	1.51	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.39	1.34	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	17.63	3.62	3.14	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	14.71	5.35	1.78	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	13.17	5.37	3.41	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.84	3.97	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	3.25	0.00	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.60	2.98	1.32	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.04	5.47	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.86	1.45	1.09	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.52	4.63	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	0.00	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	12.19	3.93	0.81	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	3.23	1.08	0.81
immature langerhans cells, donor1	11904-125F5	16.47	4.36	2.18	1.45
immature langerhans cells, donor2	11905-125F6	22.97	7.13	2.38	1.58
insula, adult, pool1	10039-101F3	9.37	2.18	1.04	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	7.15	2.93	0.33	0.98
kidney, adult, pool1	10017-101C8	18.52	4.21	1.20	1.30
kidney, fetal, pool1	10045-101F9	28.72	7.07	3.75	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.29	7.39	2.56	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.88	3.59	5.53	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.63	4.04	2.02	2.94
left atrium, adult, donor1	10079-102A7	17.98	2.72	1.63	1.63
left ventricle, adult, donor1	10078-102A6	18.20	3.03	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	31.19	1.92	4.92	1.64
leiomyoma cell line:10964C	10569-108B2	9.34	1.08	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	8.15	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	10.20	1.46	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.67	5.67	2.72	1.77
liposarcoma cell line:KMLS-1	10782-110G8	20.93	4.37	1.41	0.78
liposarcoma cell line:SW 872	10726-110A6	14.38	3.17	1.71	0.97
liver, adult, pool1	10018-101C9	26.74	3.73	2.27	0.65
liver, fetal, pool1	10086-102B5	16.93	1.88	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	19.98	2.77	1.02	1.02
locus coeruleus, adult, donor10252	10165-103B3	12.55	1.85	1.85	1.29
locus coeruleus, adult, donor10258	10375-105G6	5.64	0.85	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	10.09	2.10	0.84	2.10
lung adenocarcinoma cell line:A549	10499-107C4	40.83	3.46	5.95	2.21
lung adenocarcinoma cell line:PC-14	10408-106B3	29.64	6.89	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	20.30	6.33	1.98	0.13
lung, adult, pool1	10019-101D1	48.43	8.62	6.97	1.42
lung, fetal, donor1	10068-101I5	168.96	13.98	31.39	2.28
lung, right lower lobe, adult, donor1	10075-102A3	51.32	16.04	10.54	6.87
lymph node, adult, donor1	10077-102A5	26.98	7.57	2.37	1.42
lymphangiectasia cell line:DS-1	10727-110A7	49.75	7.45	7.23	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.56	4.53	1.36	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.00	7.65	5.10	0.85
mature adipocyte, donor1	12231-129F8	7.10	1.78	1.33	0.89
mature adipocyte, donor2	12232-129F9	7.89	1.45	0.21	0.42
mature adipocyte, donor3	12233-129G1	7.35	0.24	0.71	0.00
mature adipocyte, donor4	12234-129G2	5.00	0.79	1.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	38.60	10.25	4.77	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.22	1.29	1.10	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	4.77	0.95	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	0.43	0.85	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	10.97	1.01	0.84	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	17.40	1.49	1.91	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.82	0.72	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	36.34	1.95	1.30	1.95
medulla oblongata, adult, donor10252	10155-103A2	19.51	2.63	1.70	0.15
medulla oblongata, adult, pool1	10038-101F2	20.98	3.75	1.55	1.14
medulla oblongata, newborn, donor10223	10361-105F1	20.14	1.04	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	42.73	6.20	13.51	3.76
medulloblastoma cell line:ONS-76	10759-110E3	15.16	4.40	1.96	0.49
melanoma cell line:COLO 679	10514-107E1	19.84	2.73	1.72	1.15
melanoma cell line:G-361	10465-106H6	6.52	2.71	1.90	0.54
meningioma cell line:HKBMM	10691-109F7	30.75	2.17	2.17	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	5.29	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	34.22	9.85	4.67	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.74	2.15	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	0.91	0.73	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.96	1.55	0.70	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.25	1.73	2.70	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	33.32	0.69	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	1.89	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.62	1.96	3.11	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.38	1.06	0.27	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.91	1.89	0.68	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.24	2.70	0.71	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.88	1.65	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.55	1.52	0.55	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.31	2.44	0.35	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.21	1.02	0.41	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	3.24	1.80	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.52	0.72	0.21	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.75	2.05	0.68	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.55	2.10	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.52	1.05	0.60	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.88	1.31	0.79	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.51	1.47	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.88	3.72	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.16	2.53	5.89	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	3.20	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	0.77	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.64	0.79	1.57	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	1.85	2.77	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.94	1.41	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.12	1.35	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	0.79	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.83	0.58	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.04	1.78	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.61	0.96	0.96	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	3.67	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.06	1.01	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	2.46	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	1.72	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.17	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.93	2.13	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.28	0.78	1.94	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.15	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.14	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	2.15	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.05	1.25	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	0.69	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	0.00	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.67	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.33	1.19	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.15	0.77	6.19	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	72.29	2.60	11.10	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.12	0.46	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.84	1.85	1.64	0.82
mesothelioma cell line:Mero-25	10850-111F4	9.76	2.04	2.04	0.68
mesothelioma cell line:Mero-41	10851-111F5	15.16	2.44	0.24	2.93
mesothelioma cell line:Mero-48a	10852-111F6	16.83	1.77	0.44	3.32
mesothelioma cell line:Mero-82	10853-111F7	19.18	2.63	0.79	5.26
mesothelioma cell line:Mero-83	10854-111F8	13.96	4.43	1.70	5.79
mesothelioma cell line:Mero-84	10855-111F9	10.36	0.51	1.01	1.52
mesothelioma cell line:Mero-95	10856-111G1	12.22	4.76	0.41	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	30.48	3.31	2.32	4.97
mesothelioma cell line:NCI-H226	10846-111E9	12.13	1.45	1.63	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	15.72	2.39	2.39	5.64
mesothelioma cell line:NCI-H28	10845-111E8	26.46	5.09	2.80	4.58
mesothelioma cell line:No36	10857-111G2	14.68	0.98	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	9.48	2.44	1.08	3.79
migratory langerhans cells, donor1	11901-125F2	14.39	3.65	0.19	1.15
migratory langerhans cells, donor2	11902-125F3	17.95	4.27	1.71	0.49
migratory langerhans cells, donor3	11903-125F4	17.23	2.69	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.06	2.29	1.96	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	3.60	1.27	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.96	4.15	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.17	6.47	4.19	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	21.25	8.32	2.96	0.74
myeloma cell line:PCM6	10474-106I6	156.16	18.58	11.86	15.22
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	1.01	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.18	3.14	1.77	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.24	1.00	0.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.07	0.37	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	7.18	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	18.63	4.37	3.91	0.46
neuroblastoma cell line:NB-1	10539-107G8	27.50	4.68	2.25	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	10.76	1.27	1.27	0.00
neuroblastoma cell line:NH-12	10555-107I6	9.50	1.86	2.05	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.16	1.66	3.80	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	14.57	1.90	1.90	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	16.91	2.62	1.81	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.72	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.10	3.46	1.86	1.33
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	43.29	23.34	4.40	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.94	2.24	0.32	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.88	2.89	1.58	1.31
nucleus accumbens, adult, pool1	10037-101F1	9.94	2.34	0.94	0.37
occipital cortex - adult, donor10196	10172-103C1	18.54	2.06	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	22.27	2.68	2.15	1.34
occipital cortex, newborn, donor10223	10355-105E4	9.10	0.73	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	3.94	0.79	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	16.73	3.86	1.72	1.29
occipital pole, adult, pool1	10036-101E9	7.96	1.42	0.32	0.16
olfactory region, adult	10195-103E6	5.73	1.53	0.57	0.38
optic nerve, donor1	10277-104E7	12.01	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.65	4.44	2.96	1.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.93	5.22	2.47	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.43	2.20	0.51	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.75	5.08	1.62	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	11.17	2.65	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	15.88	5.61	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	29.05	3.61	4.67	1.27
ovary, adult, pool1	10020-101D2	15.20	2.97	2.18	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.17	1.65	0.37	0.00
pancreas, adult, donor1	10049-101G4	45.15	10.35	4.70	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	11.46	4.75	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	13.12	3.24	4.26	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	8.61	4.64	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	10.89	1.46	0.55	0.09
parietal cortex, adult, donor10258	10373-105G4	2.94	2.94	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	10.35	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	12.83	2.00	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	10.93	1.50	0.97	0.35
parietal lobe, fetal, donor1	10072-101I9	17.46	1.94	3.88	5.82
parietal lobe, newborn, donor10223	10356-105E5	12.34	0.75	1.50	1.50
parotid gland, adult	10199-103F1	23.43	6.17	1.23	0.00
penis, adult	10200-103F2	33.30	5.91	4.30	5.37
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	13.95	2.23	1.86	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.07	4.81	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	15.48	1.94	0.65	2.58
pineal gland, adult, donor10252	10160-103A7	26.06	5.92	2.37	3.55
pineal gland, adult, donor10258	10377-105G8	25.08	5.02	2.51	2.51
pituitary gland - adult, donor10196	10180-103C9	24.28	3.04	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	23.97	2.08	3.13	1.56
pituitary gland, adult, donor10258	10378-105G9	17.02	5.11	0.85	2.55
placenta, adult, pool1	10021-101D3	22.68	5.05	2.80	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	13.90	4.11	0.93	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.24	3.42	0.93	2.02
pons, adult, pool1	10033-101E6	16.96	2.32	1.46	0.34
postcentral gyrus, adult, pool1	10032-101E5	10.20	1.74	1.05	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	20.91	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	3.20	1.89	2.62
prostate cancer cell line:PC-3	10439-106E7	62.80	6.90	8.53	4.36
prostate, adult, pool1	10022-101D4	26.48	5.44	3.08	1.18
putamen, adult, donor10196	10176-103C5	9.91	1.42	1.42	0.24
putamen, adult, donor10252	10152-102I8	11.76	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	8.74	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.01	0.97	0.48	0.97
putamen, newborn, donor10223	10365-105F5	20.24	2.25	1.50	4.50
rectal cancer cell line:TT1TKB	10469-106I1	15.71	6.40	0.87	0.29
rectum, fetal, donor1	10067-101I4	29.21	16.69	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.05	5.72	3.39	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.11	1.24	0.00	2.49
retina, adult, pool1	10030-101E3	57.15	5.86	7.95	2.39
retinoblastoma cell line:Y79	10475-106I7	2.34	2.34	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	13.40	5.16	1.23	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	47.52	10.97	4.78	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	12.79	3.40	0.65	1.46
salivary acinar cells, donor2	11772-123I8	13.77	5.78	0.83	1.24
salivary acinar cells, donor3	11773-123I9	19.86	12.58	1.99	0.66
salivary gland, adult, pool1	10093-102C3	34.32	10.30	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.51	5.90	0.59	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.99	4.23	0.47	1.88
seminal vesicle, adult	10201-103F3	18.52	5.82	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.88	3.16	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.56	1.01	2.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	13.16	2.55	3.63	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	27.74	7.18	3.21	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.97	9.68	1.81	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	7.80	3.55	4.26
skeletal muscle, adult, pool1	10023-101D5	29.86	3.12	2.40	1.20
skeletal muscle, fetal, donor1	10066-101I3	26.13	9.05	3.02	4.02
skin, adult, donor1	10074-102A2	13.57	6.79	6.79	6.79
skin, fetal, donor1	10065-101I2	19.57	3.16	3.79	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.00	2.00	1.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	22.69	5.67	7.56	4.73
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.94	3.47	2.89	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	14.01	3.30	2.14	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.95	1.13	0.16	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.04	6.97	6.97	0.87
small intestine, adult, pool1	10024-101D6	19.71	8.00	2.03	1.19
small intestine, fetal, donor1	10064-101I1	18.92	5.41	3.19	4.42
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	5.64	4.62	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	21.19	5.17	1.81	3.10
somatostatinoma cell line:QGP-1	10781-110G7	17.15	5.90	1.88	0.00
spinal cord - adult, donor10196	10181-103D1	22.71	3.90	0.46	2.29
spinal cord, adult, donor10252	10159-103A6	21.29	3.94	1.58	0.79
spinal cord, adult, donor10258	10369-105F9	4.84	0.69	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	21.34	6.10	2.44	4.27
spinal cord, newborn, donor10223	10359-105E8	9.64	0.46	0.92	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	13.29	2.54	0.60	0.60
spleen, adult, pool1	10025-101D7	30.18	9.36	4.52	1.21
spleen, fetal, pool1	10044-101F8	51.33	10.49	8.50	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	33.85	9.63	3.93	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.16	3.42	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.42	2.80	3.15	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	11.34	3.13	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.92	3.49	0.90	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	25.42	5.51	1.27	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.77	2.54	0.42	0.00
stomach, fetal, donor1	10062-101H8	26.70	19.22	3.20	0.00
submaxillary gland, adult	10202-103F4	50.13	11.39	3.99	3.42
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	325.64
substantia nigra, adult, donor10252	10158-103A5	27.42	3.53	2.28	0.83
substantia nigra, adult, donor10258	10371-105G2	5.17	1.55	0.52	2.59
substantia nigra, newborn, donor10223	10358-105E7	23.32	4.24	0.71	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.30	7.80	1.60	0.92
temporal lobe, adult, pool1	10031-101E4	8.73	1.53	1.19	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	18.52	2.85	5.70	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	1.32	7.47	0.88
tenocyte, donor1	11763-123H8	10.82	1.75	1.40	1.05
tenocyte, donor2	11765-123I1	16.79	0.00	1.14	0.76
tenocyte, donor3	11768-123I4	15.94	1.48	2.22	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.74	3.40	2.55	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	26.21	5.55	7.09	4.01
teratocarcinoma cell line:PA-1	10807-111A6	29.29	4.34	2.48	2.17
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.47	5.84	5.46	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	3.78	3.03	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.88	5.45	2.94	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.99	5.21	3.91	3.58
testis, adult, pool1	10026-101D8	14.60	3.01	4.19	0.43
testis, adult, pool2	10096-102C6	16.24	6.32	3.16	5.41
thalamus - adult, donor10196	10168-103B6	24.29	2.21	0.00	4.42
thalamus, adult, donor10252	10154-103A1	21.25	1.88	2.50	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.59	1.15	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	8.05	1.15	0.00	1.15
throat, adult	10209-103G2	30.96	6.74	3.50	0.00
throat, fetal, donor1	10061-101H7	23.46	7.31	4.27	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	37.36	8.74	4.17	2.38
thymus, adult, pool1	10027-101D9	45.43	7.95	7.65	0.89
thymus, fetal, pool1	10043-101F7	73.77	9.46	9.14	3.32
thyroid carcinoma cell line:KHM-5M	10776-110G2	11.70	3.19	0.80	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	17.46	3.63	2.24	1.54
thyroid, adult, pool1	10028-101E1	42.18	6.07	7.93	1.96
thyroid, fetal, donor1	10060-101H6	44.82	6.86	7.91	7.91
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	12.32	0.00	6.16
tongue, adult	10203-103F5	21.40	4.65	1.40	0.23
tongue, fetal, donor1	10059-101H5	25.62	3.15	4.34	1.97
tonsil, adult, pool1	10047-101G2	61.61	15.43	7.01	1.70
trachea, adult, pool1	10029-101E2	28.79	7.53	2.70	1.06
trachea, fetal, donor1	10058-101H4	25.77	5.77	5.00	4.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.74	1.06	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	17.12	11.14	1.62	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.21	5.95	3.92	3.29
tridermal teratoma cell line:HGRT	10694-109G1	9.51	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	17.78	3.56	1.19	1.02
umbilical cord, fetal, donor1	10057-101H3	18.78	0.00	0.00	4.17
uterus, adult, pool1	10100-102D1	39.93	5.97	3.92	3.41
uterus, fetal, donor1	10055-101H1	20.48	5.12	7.68	3.58
vagina, adult	10204-103F6	32.96	8.40	3.88	1.94
vein, adult	10191-103E2	28.50	7.23	5.04	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.78	6.94	1.60	5.07